search
Back to results

The Thiamine Administration After Cardiac Surgery Trial (TAACS)

Primary Purpose

Lactate Blood Increase, Thiamine Deficiency

Status
Completed
Phase
Phase 4
Locations
Belgium
Study Type
Interventional
Intervention
Thiamine 500 MG
Placebo
Sponsored by
Sarah Saxena
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lactate Blood Increase

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients scheduled for elective cardiac surgery with extra-corporeal circulation in the CHU de Charleroi between November 2020 and December 2021. Written informed consent will be obtained from each patient/ family member participating in the study.

Exclusion Criteria:

  • Patients already supplemented with vitamins
  • Patients with an allergy to thiamine
  • Patients who are priorly treated with linezolide, antiretrovirals and/or metformin treatment within 48 hours preoperatively
  • Patients with mitochondrial disorders
  • Patients with Child Pugh C cirrhosis
  • Patients with a history of epilepsy with tonic-clonic movements postoperatively.
  • Pregnant patients

Sites / Locations

  • CHU-Charleroi Hopital Civil Marie Curie

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Thiamine

Placebo

Arm Description

Patients in this arm will receive a solution of 500 mg of Thiamine Hydrocloride in a solution of 100 ml of NaCl 0.9%.

Patients in this arm will receive a solution of 100 ml of NaCl 0.9% alone.

Outcomes

Primary Outcome Measures

Lactate
Lactate level will be specifically be measured 24h post-ICU admission to evaluate the effect of thiamine versus placebo.

Secondary Outcome Measures

Fluid balance
The influence of thiamine/placebo on the use of volume expansion during ICU stay will also be evaluated
Inotropes
The influence of thiamine: placebo on the use of inotropes during ICU stay will also be evaluated
Mechanical ventilation
The influence of thiamine/ placebo on extubation time will also be evaluated.
Length of ICU stay
The influence of thiamine/ placebo on ICU discharge will also be evaluated.
Length of hospital stay
The influence of thiamine/ placebo on hospital discharge will also be evaluated.

Full Information

First Posted
November 17, 2020
Last Updated
November 16, 2022
Sponsor
Sarah Saxena
Collaborators
CHU de Charleroi
search

1. Study Identification

Unique Protocol Identification Number
NCT04641104
Brief Title
The Thiamine Administration After Cardiac Surgery Trial
Acronym
TAACS
Official Title
The Thiamine Administration After Cardiac Surgery Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
November 20, 2020 (Actual)
Primary Completion Date
October 3, 2022 (Actual)
Study Completion Date
October 3, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Sarah Saxena
Collaborators
CHU de Charleroi

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Thiamine (Vitamin B1) is essential for cell function and as a co-factor of the enzyme Pyruvate Dehydrogenase to initiate the Krebs cycle and thus the aerobic metabolism of glucose. We hypothesize that thiamine supplementation improves the clearance of lactate in the first 24 hours after cardiac surgery with extracorporeal circulation in patients with high lactate concentration.
Detailed Description
Thiamine (Vitamin B1) is essential for cell function and as a co-factor of the enzyme Pyruvate Dehydrogenase to initiate the Krebs cycle and thus the aerobic metabolism of glucose. Thiamine deficiency, can be caused by alcoholism or bariatric surgery and is associated with severe complications such as Wernicke's encephalopathy or Beri-Beri syndrome. Thiamine deficiency can also be the cause for an increase in lactate levels due to the transformation of pyruvate to lactate. An increase in lactate levels is associated with a worse prognostic. A decrease is, on the contrary, associated with an improved prognostic, during CPR and also after cardiac arrest. Recently, studies have shown that thiamine deficiency is underdiagnosed in ICU patients. On top of this, extra-corporeal circulation can worsen this deficiency. This could explain why certain on-pump cardiac surgery patients have increased lactate levels post-operatively, despite optimal blood pressure, cardiac output, diuresis, peripheral perfusion Donnino et al have shown that in a sepsis context thiamine administration improved lactate clearance during the first 24 hours of ICU admission and improved mortality rates at 28 days post-ICU admission. Therefore, the hypothesis of this study is that thiamine supplementation improves the clearance of lactate in the first 24 hours after cardiac surgery with extracorporeal circulation in patients with high lactate concentration.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lactate Blood Increase, Thiamine Deficiency

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
This is a monocentric randomized, controlled, double blind study in patients undergoing elective cardiac surgery with extra corporal circulation. Anesthesia management of these patients is standardised in terms of volume-controlled ventilation, fluid and inotropes management. Randomization of 100 patients for the administration, of a solution of 500 mg of Thiamine Hydrocloride in a solution of 100 ml of NaCl 0.9% versus a solution of 100 ml of NaCl 0.9% alone in adult patients (≥ 18 years-old) with a lactate ≥ 2 mmol / L in the first 6 hours of ICU admission.
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Thiamine
Arm Type
Experimental
Arm Description
Patients in this arm will receive a solution of 500 mg of Thiamine Hydrocloride in a solution of 100 ml of NaCl 0.9%.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Patients in this arm will receive a solution of 100 ml of NaCl 0.9% alone.
Intervention Type
Drug
Intervention Name(s)
Thiamine 500 MG
Other Intervention Name(s)
Thiamine
Intervention Description
A solution of 500 mg of Thiamine Hydrocloride in a solution of 100 ml of NaCl 0.9% will be administered post-cardiac surgery in patients with lactate levels ≥ 2 mmol / L in the first 6 hours post-ICU admission.
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
100 ml of NaCl 0.9% will be administered in the placebo group.
Primary Outcome Measure Information:
Title
Lactate
Description
Lactate level will be specifically be measured 24h post-ICU admission to evaluate the effect of thiamine versus placebo.
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Fluid balance
Description
The influence of thiamine/placebo on the use of volume expansion during ICU stay will also be evaluated
Time Frame
48 hours
Title
Inotropes
Description
The influence of thiamine: placebo on the use of inotropes during ICU stay will also be evaluated
Time Frame
48 hours
Title
Mechanical ventilation
Description
The influence of thiamine/ placebo on extubation time will also be evaluated.
Time Frame
48 hours
Title
Length of ICU stay
Description
The influence of thiamine/ placebo on ICU discharge will also be evaluated.
Time Frame
5 days
Title
Length of hospital stay
Description
The influence of thiamine/ placebo on hospital discharge will also be evaluated.
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients scheduled for elective cardiac surgery with extra-corporeal circulation in the CHU de Charleroi between November 2020 and December 2021. Written informed consent will be obtained from each patient/ family member participating in the study. Exclusion Criteria: Patients already supplemented with vitamins Patients with an allergy to thiamine Patients who are priorly treated with linezolide, antiretrovirals and/or metformin treatment within 48 hours preoperatively Patients with mitochondrial disorders Patients with Child Pugh C cirrhosis Patients with a history of epilepsy with tonic-clonic movements postoperatively. Pregnant patients
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
MIchael Piagnerelli, MD; PHD
Organizational Affiliation
CHU de Charleroi, Belgium
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU-Charleroi Hopital Civil Marie Curie
City
Charleroi
State/Province
Hainaut
Country
Belgium

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
17429582
Citation
Frank RA, Leeper FJ, Luisi BF. Structure, mechanism and catalytic duality of thiamine-dependent enzymes. Cell Mol Life Sci. 2007 Apr;64(7-8):892-905. doi: 10.1007/s00018-007-6423-5.
Results Reference
result
PubMed Identifier
28432843
Citation
Collie JTB, Greaves RF, Jones OAH, Lam Q, Eastwood GM, Bellomo R. Vitamin B1 in critically ill patients: needs and challenges. Clin Chem Lab Med. 2017 Oct 26;55(11):1652-1668. doi: 10.1515/cclm-2017-0054.
Results Reference
result
PubMed Identifier
27002274
Citation
Flannery AH, Adkins DA, Cook AM. Unpeeling the Evidence for the Banana Bag: Evidence-Based Recommendations for the Management of Alcohol-Associated Vitamin and Electrolyte Deficiencies in the ICU. Crit Care Med. 2016 Aug;44(8):1545-52. doi: 10.1097/CCM.0000000000001659.
Results Reference
result
PubMed Identifier
20181242
Citation
Nichol AD, Egi M, Pettila V, Bellomo R, French C, Hart G, Davies A, Stachowski E, Reade MC, Bailey M, Cooper DJ. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care. 2010;14(1):R25. doi: 10.1186/cc8888. Epub 2010 Feb 24.
Results Reference
result
PubMed Identifier
19325467
Citation
Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009 May;37(5):1670-7. doi: 10.1097/CCM.0b013e31819fcf68.
Results Reference
result
PubMed Identifier
23649098
Citation
Sterling SA, Puskarich MA, Shapiro NI, Trzeciak S, Kline JA, Summers RL, Jones AE; Emergency Medicine Shock Research Network (EMSHOCKNET). Characteristics and outcomes of patients with vasoplegic versus tissue dysoxic septic shock. Shock. 2013 Jul;40(1):11-4. doi: 10.1097/SHK.0b013e318298836d.
Results Reference
result
PubMed Identifier
25479113
Citation
Casserly B, Phillips GS, Schorr C, Dellinger RP, Townsend SR, Osborn TM, Reinhart K, Selvakumar N, Levy MM. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med. 2015 Mar;43(3):567-73. doi: 10.1097/CCM.0000000000000742.
Results Reference
result
PubMed Identifier
29047411
Citation
Vellinga NAR, Boerma EC, Koopmans M, Donati A, Dubin A, Shapiro NI, Pearse RM, van der Voort PHJ, Dondorp AM, Bafi T, Fries M, Akarsu-Ayazoglu T, Pranskunas A, Hollenberg S, Balestra G, van Iterson M, Sadaka F, Minto G, Aypar U, Hurtado FJ, Martinelli G, Payen D, van Haren F, Holley A, Gomez H, Mehta RL, Rodriguez AH, Ruiz C, Canales HS, Duranteau J, Spronk PE, Jhanji S, Hubble S, Chierego M, Jung C, Martin D, Sorbara C, Bakker J, Ince C; microSOAP study group. Mildly elevated lactate levels are associated with microcirculatory flow abnormalities and increased mortality: a microSOAP post hoc analysis. Crit Care. 2017 Oct 18;21(1):255. doi: 10.1186/s13054-017-1842-7.
Results Reference
result
PubMed Identifier
15286537
Citation
Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, Tomlanovich MC. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004 Aug;32(8):1637-42. doi: 10.1097/01.ccm.0000132904.35713.a7.
Results Reference
result
PubMed Identifier
20179283
Citation
Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010 Feb 24;303(8):739-46. doi: 10.1001/jama.2010.158.
Results Reference
result
PubMed Identifier
20463176
Citation
Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, Willemsen SP, Bakker J; LACTATE study group. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010 Sep 15;182(6):752-61. doi: 10.1164/rccm.200912-1918OC. Epub 2010 May 12.
Results Reference
result
PubMed Identifier
30813144
Citation
Pan J, Peng M, Liao C, Hu X, Wang A, Li X. Relative efficacy and safety of early lactate clearance-guided therapy resuscitation in patients with sepsis: A meta-analysis. Medicine (Baltimore). 2019 Feb;98(8):e14453. doi: 10.1097/MD.0000000000014453.
Results Reference
result
PubMed Identifier
17583412
Citation
Donnino MW, Miller J, Goyal N, Loomba M, Sankey SS, Dolcourt B, Sherwin R, Otero R, Wira C. Effective lactate clearance is associated with improved outcome in post-cardiac arrest patients. Resuscitation. 2007 Nov;75(2):229-34. doi: 10.1016/j.resuscitation.2007.03.021. Epub 2007 Jun 20.
Results Reference
result
PubMed Identifier
26771781
Citation
Donnino MW, Andersen LW, Chase M, Berg KM, Tidswell M, Giberson T, Wolfe R, Moskowitz A, Smithline H, Ngo L, Cocchi MN; Center for Resuscitation Science Research Group. Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study. Crit Care Med. 2016 Feb;44(2):360-7. doi: 10.1097/CCM.0000000000001572.
Results Reference
result
PubMed Identifier
24412011
Citation
Costa NA, Gut AL, de Souza Dorna M, Pimentel JA, Cozzolino SM, Azevedo PS, Fernandes AA, Zornoff LA, de Paiva SA, Minicucci MF. Serum thiamine concentration and oxidative stress as predictors of mortality in patients with septic shock. J Crit Care. 2014 Apr;29(2):249-52. doi: 10.1016/j.jcrc.2013.12.004. Epub 2013 Dec 14. Erratum In: J Crit Care. 2016 Dec;36:311.
Results Reference
result
PubMed Identifier
20646908
Citation
Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP, Ngo L. Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010 Dec;25(4):576-81. doi: 10.1016/j.jcrc.2010.03.003. Epub 2010 Jun 19.
Results Reference
result

Learn more about this trial

The Thiamine Administration After Cardiac Surgery Trial

We'll reach out to this number within 24 hrs